These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38067654)

  • 1. Application of Accelerated Predictive Stability Studies in Extemporaneously Compounded Formulations of Chlorhexidine to Assess the Shelf Life.
    González-González O; Ballesteros MP; Torrado JJ; Serrano DR
    Molecules; 2023 Dec; 28(23):. PubMed ID: 38067654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug Stability: ICH versus Accelerated Predictive Stability Studies.
    González-González O; Ramirez IO; Ramirez BI; O'Connell P; Ballesteros MP; Torrado JJ; Serrano DR
    Pharmaceutics; 2022 Oct; 14(11):. PubMed ID: 36365143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of ursodiol in an extemporaneously compounded oral liquid.
    Johnson CE; Nesbitt J
    Am J Health Syst Pharm; 1995 Aug; 52(16):1798-1800. PubMed ID: 8528836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicochemical Stability of Compounded Amlodipine Besylate Suspensions in PCCA Base, SuspendIt.
    Graves RA; Mandal TK; Bostanian LA; Nguyen AT; Swopes D; Morris TC; Pramar YV
    Int J Pharm Compd; 2019; 23(6):519-527. PubMed ID: 31751949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation and accelerated stability studies for an extemporaneous suspension of amiodarone hydrochloride.
    Alexander KS; Thyagarajapuram N
    Int J Pharm Compd; 2003; 7(5):389-93. PubMed ID: 23979771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical appraisal of commercially available suspending vehicles for extemporaneous compounding of cardiovascular medicines: physical and chemical stability mini review.
    Thrimawithana TR; D'Amore S; Dib Y; Fadavi Firooz N; Fakhouri W; Saeed A; Allahham A
    Pharm Dev Technol; 2019 Jun; 24(5):529-538. PubMed ID: 30238838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of an extemporaneously compounded levothyroxine sodium oral liquid.
    Boulton DW; Fawcett JP; Woods DJ
    Am J Health Syst Pharm; 1996 May; 53(10):1157-61. PubMed ID: 8734676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shelf-life of a 2.5% sodium hypochlorite solution as determined by Arrhenius equation.
    Nicoletti MA; Siqueira EL; Bombana AC; Oliveira GG
    Braz Dent J; 2009; 20(1):27-31. PubMed ID: 19466227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability-indicating LC-MS Method for Determination of Stability of Extemporaneously Compounded Buprenorphine Oral Syringes for Neonatal Abstinence Syndrome.
    Rochani A; Nguyen V; Becker R; Kraft W; Kaushal G
    J Pediatr Pharmacol Ther; 2021; 26(4):395-404. PubMed ID: 34035685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and stability of an extemporaneous 0.02% chlorhexidine digluconate ophthalmic solution.
    Lin SC; Huang CF; Shen LJ; Wang HJ; Lin CY; Wu FL
    J Formos Med Assoc; 2015 Dec; 114(12):1162-9. PubMed ID: 25260549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of an alternative extemporaneous captopril fast-dispersing tablet formulation versus an extemporaneous oral liquid formulation.
    Pabari RM; McDermott C; Barlow J; Ramtoola Z
    Clin Ther; 2012 Nov; 34(11):2221-9. PubMed ID: 23149007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of buffer and antioxidant on stability of a mercaptopurine suspension.
    Aliabadi HM; Romanick M; Desai S; Lavasanifar A
    Am J Health Syst Pharm; 2008 Mar; 65(5):441-7. PubMed ID: 18281736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation and stability of an extemporaneously compounded oral solution of chlorpromazine HCl.
    Prohotsky DL; Juba KM; Zhao F
    J Pain Palliat Care Pharmacother; 2014 Dec; 28(4):367-70. PubMed ID: 25338106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of an extemporaneously compounded clonidine hydrochloride oral liquid.
    Levinson ML; Johnson CE
    Am J Hosp Pharm; 1992 Jan; 49(1):122-5. PubMed ID: 1570852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of an extemporaneously compounded baclofen oral liquid.
    Johnson CE; Hart SM
    Am J Hosp Pharm; 1993 Nov; 50(11):2353-5. PubMed ID: 8266961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of acetazolamide in suspension compounded from tablets.
    Alexander KS; Haribhakti RP; Parker GA
    Am J Hosp Pharm; 1991 Jun; 48(6):1241-4. PubMed ID: 1858804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Manufacturer on the Compounding of Omeprazole Suspensions and Their Stability Assessment.
    Meissner S; Bansal M; Dela CPD; Hanning S; Svirskis D
    Int J Pharm Compd; 2020; 24(2):140-147. PubMed ID: 32196476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability-indicating HPLC method to determine the stability of extemporaneously prepared vancomycin oral solution cups.
    Rochani A; Nguyen V; Becker R; Kaushal G
    Am J Health Syst Pharm; 2022 Jan; 79(1):e34-e40. PubMed ID: 34226929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Influence of Tablet Formulation, Drug Concentration, and pH Modification on the Stability of Extemporaneously Compounded Levothyroxine Suspensions.
    Svirskis D; Lin SW; Brown H; Sangaroomthong A; Shin D; Wang Z; Xu H; Dean R; Vareed P; Jensen M; Wu Z
    Int J Pharm Compd; 2018; 22(2):164-171. PubMed ID: 29877863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerated Stability Assessment of Extemporaneously Compounded Amiloride Nasal Spray.
    Sayre CL; Renninger B; Reaves-Mckee T; Imhoff A; Gali C; Thomas C; Patel N; Battaglia M; Davies S; Yellepeddi VK
    Int J Pharm Compd; 2024; 28(3):246-248. PubMed ID: 38768504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.